antibiotics emerging pathogens
antibiotic-resistant strains pathogenic bacteria increasingly prevalent hospitals community new antibiotics needed combat bacterial pathogens progress developing slow historically antibiotics come small set molecular scaffolds whose functional lifetimes extended generations synthetic tailoring emergence multidrug resistance among latest generation pathogens suggests discovery new scaffolds priority promising approaches scaffold discovery emerging include mining underexplored microbial niches natural products designing screens avoid rediscovering old scaffolds repurposing libraries synthetic molecules use antibiotics
